Patents Assigned to Biovail Laboratories International (Barbados) S.R.L.
  • DIHYDROTETRABENANZINE FOR THE TREATMENT OF ANXIETY
    Publication number: 20110190333
    Abstract: The invention provides a 3,11b-cis-dihydrotetrabenazine of the formula (Ib): or a pharmaceutically acceptable salt thereof for use in the prophylaxis or treatment of anxiety.
    Type: Application
    Filed: June 12, 2009
    Publication date: August 4, 2011
    Applicant: Biovail Laboratories International (Barbados) S.R.L.
    Inventors: Ben Grayson, Roger Anthony Oakes, Andrew John Duffield
  • Pharmaceutical compounds
    Patent number: 7956065
    Abstract: This application describes method of treating dementia and cognitive deficits associated with dementia that involve administration of dihydrotetrabenazine, and isomers and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: June 7, 2011
    Assignee: Biovail Laboratories International (Barbados) S.R.L.
    Inventor: Philip Paul Nichols
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20110053866
    Abstract: The present invention provides for a pharmaceutical composition that includes tetrabenazine and a release-retarding agent; and a method of treating a hyperkinetic movement disorder (e.g., Huntington's disease, chorea associated with Huntington's disease, hemiballismus, senile chorea, tic disorders, tardive dyskinesia, myoclonus, dystonia and/or Tourette's syndrome). The method includes administering an effective amount of the pharmaceutical composition, for a period of time effective to treat the hyperkinetic movement disorder.
    Type: Application
    Filed: August 12, 2010
    Publication date: March 3, 2011
    Applicant: Biovail Laboratories International (Barbados) S.R.L.
    Inventors: Andrew John Duffield, Graham Jackson, Steven E. Frisbee, Okponanabofa Eradiri, John CK Lai
  • USE OF 3, 11B-CIS-DIHYDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND AUTOIMMUNE MYELITIS
    Publication number: 20110039877
    Abstract: The invention provides a compound for use in treating multiple sclerosis wherein the compound is a 3, 11b-cis-dihydrotetrabenazine of the formula (Ia): or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 29, 2008
    Publication date: February 17, 2011
    Applicant: Biovail Laboratories International (Barbados) S.R.L.
    Inventor: Andrew John Duffield
  • PHARMACEUTICAL COMPOUNDS
    Publication number: 20100087476
    Abstract: This application describes methods of treatment and/or prophylaxis of asthma that involve administration of dihydrotetrabenazine, and isomers and/or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 8, 2009
    Publication date: April 8, 2010
    Applicant: Biovail Laboratories International (Barbados) S.R.L.
    Inventors: Andrew John Duffield, Neil Andrew Williams
  • PHARMACEUTICAL COMPOUNDS
    Publication number: 20100063086
    Abstract: This application describes method of treating dementia and cognitive deficits associated with dementia that involve administration of dihydrotetrabenazine, and isomers and/or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 8, 2009
    Publication date: March 11, 2010
    Applicant: Biovail Laboratories International (Barbados) S.R.L.
    Inventor: Philip Paul Nichols
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100055133
    Abstract: The present invention provides for a pharmaceutical composition that includes tetrabenazine and a release-retarding agent; and a method of treating a hyperkinetic movement disorder (e.g., Huntington's disease, chorea associated with Huntington's disease, hemiballismus, senile chorea, tic disorders, tardive dyskinesia, myoclonlus, dystoniia and/or Tourette's syndrome). The method includes administering an effective amount of the pharmaceutical composition, for a period of time effective to treat the hyperkinetic movement disorder.
    Type: Application
    Filed: August 12, 2009
    Publication date: March 4, 2010
    Applicant: Biovail Laboratories International (Barbados) S.R.L
    Inventors: Andrew John Duffield, Graham Jackson, Steven E. Frisbee